KOREA PHARMA Co., Ltd. announced a private placement of series 3 bearer type no interest no guarantee private placement convertible bonds for an aggregate gross proceeds of KRW 50,000,000,000 on October 22, 2021. The transaction is expected to close on October 26, 2021. The transaction has been approved by the board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18,560 KRW | -1.43% | -2.47% | -21.52% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.52% | 151M | |
+37.80% | 705B | |
+32.82% | 583B | |
-3.69% | 364B | |
+20.18% | 332B | |
+4.90% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.81% | 169B |
- Stock Market
- Equities
- A032300 Stock
- News KOREA PHARMA Co., Ltd.
- KOREA PHARMA Co., Ltd. announced that it expects to receive KRW 50 billion in funding